These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3062866)

  • 1. Correlation of ultrasonic attenuation with pathologic fat and fibrosis in liver disease.
    Lin T; Ophir J; Potter G
    Ultrasound Med Biol; 1988; 14(8):729-34. PubMed ID: 3062866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-dependent ultrasonic differentiation of normal and diffusely diseased liver.
    Lin T; Ophir J; Potter G
    J Acoust Soc Am; 1987 Oct; 82(4):1131-8. PubMed ID: 3316337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method.
    Itoh K; Yasuda Y; Suzuki O; Itoh H; Itoh T; Tsao JW; Konishi T; Koyano A
    J Clin Ultrasound; 1988 Oct; 16(8):553-62. PubMed ID: 3152399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound attenuation measurements of the liver in vivo using a commercial sector scanner.
    Garra BS; Shawker TH; Nassi M; Russell MA
    Ultrason Imaging; 1984 Oct; 6(4):396-407. PubMed ID: 6399170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence of ultrasonic attenuation of liver on pathologic fat and fibrosis: examination with experimental fatty liver and liver fibrosis models.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Fusamoto H; Imai Y; Kamada T
    Ultrasound Med Biol; 1992; 18(8):657-66. PubMed ID: 1440987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of sound speed with tissue constituents in normal and diffuse liver disease.
    Lin T; Ophir J; Potter G
    Ultrason Imaging; 1987 Jan; 9(1):29-40. PubMed ID: 3299967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method.
    Fujii Y; Taniguchi N; Itoh K; Shigeta K; Wang Y; Tsao JW; Kumasaki K; Itoh T
    J Ultrasound Med; 2002 Jul; 21(7):783-8. PubMed ID: 12099567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo acoustic attenuation in liver: correlations with blood tests and histology.
    Duerinckx A; Rosenberg K; Hoefs J; Aufrichtig D; Cole-Beuglet C; Kanel G; Lottenberg S; Ferrari LA
    Ultrasound Med Biol; 1988; 14(5):405-13. PubMed ID: 3051614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat.
    Taylor KJ; Riely CA; Hammers L; Flax S; Weltin G; Garcia-Tsao G; Conn HO; Kuc R; Barwick KW
    Radiology; 1986 Jul; 160(1):65-71. PubMed ID: 3520657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Fourier spectral shift-determined hepatic acoustic attenuation coefficients with liver biopsy findings.
    Kuni CC; Johnson TK; Crass JR; Snover DC
    J Ultrasound Med; 1989 Nov; 8(11):631-4. PubMed ID: 2687493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver.
    Wilson LS; Robinson DE; Griffiths KA; Manoharan A; Doust BD
    Ultrason Imaging; 1987 Oct; 9(4):236-47. PubMed ID: 3330337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency domain processing for ultrasonic attenuation measurement in liver.
    Wilson LS; Robinson DE; Doust BD
    Ultrason Imaging; 1984 Jul; 6(3):278-92. PubMed ID: 6396922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided B-mode ultrasound diagnosis of hepatic steatosis: a feasibility study.
    Thijssen JM; Starke A; Weijers G; Haudum A; Herzog K; Wohlsein P; Rehage J; De Korte CL
    IEEE Trans Ultrason Ferroelectr Freq Control; 2008; 55(6):1343-54. PubMed ID: 18599422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonic propagation properties (@ 100 MHz) in excessively fatty rat liver.
    O'Brien WD; Erdman JW; Hebner TB
    J Acoust Soc Am; 1988 Mar; 83(3):1159-66. PubMed ID: 3281985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of structural change in diffuse liver disease with frequency domain analysis of ultrasound.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Imai Y; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):1041-6. PubMed ID: 8514252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound in the diagnostics of fatty liver in obesity].
    Szebeni A; Tolvaj G; Stotz G
    Orv Hetil; 2010 Apr; 151(14):572-5. PubMed ID: 20332074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo measurements of ultrasound attenuation in normal or diseased liver.
    Parker KJ; Asztely MS; Lerner RM; Schenk EA; Waag RC
    Ultrasound Med Biol; 1988; 14(2):127-36. PubMed ID: 3279691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C.
    Charlotte F; Le Naour G; Bernhardt C; Poynard T; Ratziu V;
    Hum Pathol; 2010 Aug; 41(8):1178-85. PubMed ID: 20413144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.